SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)]:
SEC Accession No. 0001193125-15-316322
Filing Date
2015-09-09
Accepted
2015-09-09 21:58:17
Documents
6
Effectiveness Date
2015-09-09

Document Format Files

Seq Description Document Type Size
1 S-3MEF d13417ds3mef.htm S-3MEF 31774
2 EX-5.1 d13417dex51.htm EX-5.1 5898
3 EX-23.1 d13417dex231.htm EX-23.1 1784
4 GRAPHIC g13417g01n88.jpg GRAPHIC 10661
5 GRAPHIC g13417g18r46.jpg GRAPHIC 9106
6 GRAPHIC g13417g46j64.jpg GRAPHIC 7119
  Complete submission text file 0001193125-15-316322.txt   77662
Mailing Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121
Business Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: S-3MEF | Act: 33 | File No.: 333-206855 | Film No.: 151099948
SIC: 2836 Biological Products, (No Diagnostic Substances)